Explore

Rapid Read Rapid Read
President Trump Visits China Amid Rising Iran War Costs and FDA Leadership Change

President Trump Visits China Amid Rising Iran War Costs and FDA Leadership Change

President Trump has arrived in China as part of a diplomatic visit, marking a significant moment in U.S.-China relations. Concurrently, Pete Hegseth is under scrutiny on Capitol Hill regarding the escalating costs associated with the ongoing conflict in Iran. This development comes at a time when the U.S. is grappling with international military commitments and their financial implications. Additionally, the Food and Drug Administration (FDA) is experiencing a leadership change with the resignation of Commissioner Marty Makary. These events highlight a period of transition and challenge within U.S. political and administrative spheres.
Reuters Reuters
Makary exit may temporarily lift biotech sentiment but FDA leadership vacuum looms

Makary exit may temporarily lift biotech sentiment but FDA leadership vacuum looms

By Christy Santhosh May 13 (Reuters) - U.S. Food and Drug Administration Commissioner Dr. Marty Makary's departure comes as a positive move after a period of turmoil in the biotech sector, but until a permanent replacement is found, the industry could be under pressure, analysts and investors said.
Rapid Read Rapid Read
President Trump Appoints Kyle Diamantas as Acting FDA Chief Amid Policy Shifts

President Trump Appoints Kyle Diamantas as Acting FDA Chief Amid Policy Shifts

President Trump has appointed Kyle Diamantas as the acting commissioner of the Food and Drug Administration (FDA) following the resignation of Marty Makary. Diamantas, who previously led the FDA's Human Foods Program, is the first lawyer to head the agency, marking a significant departure from the traditional scientific or medical backgrounds of past commissioners. His appointment aligns with the Trump administration's 'Make America Healthy Again' initiative, which focuses on food policy changes. Diamantas' legal expertise is expected to play a crucial role in navigating the agency's regulatory landscape, particularly in areas such as food safety and chronic disease prevention.
AP News AP News
Supreme Court preserves access to widely used abortion pill, while lawsuit plays out

Supreme Court preserves access to widely used abortion pill, while lawsuit plays out

The Supreme Court has preserved women’s access to a drug used in the most common method of abortion, rejecting lower-court restrictions while a lawsuit continues
AP News AP News
Republican resistance to Iran war grows in the Senate as Murkowski flips

Republican resistance to Iran war grows in the Senate as Murkowski flips

Senate Republicans have again blocked Democratic legislation that would halt President Donald Trump’s war with Iran
Reuters Reuters
US Senate blocks latest bid to rein in Trump Iran war powers, support grows

US Senate blocks latest bid to rein in Trump Iran war powers, support grows

By Patricia Zengerle WASHINGTON, May 13 (Reuters) - U.S. Senate Republicans on Wednesday blocked the latest Democratic-led effort to end the Iran war until it is authorized by Congress, but the measure edged closer to passage as a third Republican voted to advance the bill.
Rapid Read Rapid Read
House Fails to Pass Resolution to Limit President Trump's Iran War Powers

House Fails to Pass Resolution to Limit President Trump's Iran War Powers

The House of Representatives failed to pass a resolution aimed at curbing President Trump's war powers in Iran, resulting in a 212-212 deadlock. The resolution, supported by Democrats and a few Republicans, sought to require congressional authorization for continued military action. Notably, Republicans Thomas Massie, Brian Fitzpatrick, and Tom Barrett broke ranks to support the measure. This vote follows a similar effort in the Senate, where a small group of Republicans joined Democrats in an unsuccessful attempt to limit the President's war powers.
Reuters Reuters
FDA commissioner Makary is resigning, sources say

FDA commissioner Makary is resigning, sources say

By Yasmeen Abutaleb WASHINGTON, May 12 (Reuters) - U.S.
AP News AP News
The Latest: Trump departs for high-stakes China summit as Iran war looms

The Latest: Trump departs for high-stakes China summit as Iran war looms

President Donald Trump has departed for Beijing to meet with China's President Xi Jinping
AP News AP News
Trump's FDA chief is out after angering pharma CEOs, vaping lobbyists and anti-abortion activists

Trump's FDA chief is out after angering pharma CEOs, vaping lobbyists and anti-abortion activists

Marty Makary is resigning as President Donald Trump's Food and Drug Administration head
AP News AP News
Trump FDA chief is leaving after angering pharma CEOs, vaping lobbyists and anti-abortion groups

Trump FDA chief is leaving after angering pharma CEOs, vaping lobbyists and anti-abortion groups

Marty Makary is resigning as President Donald Trump's Food and Drug Administration head
Rapid Read Rapid Read
President Trump Pushes for Ban on Institutional Homeowners to Protect American Dream

President Trump Pushes for Ban on Institutional Homeowners to Protect American Dream

President Donald Trump is advocating for Congress to pass a ban on institutional investors owning single-family homes, a key component of the 21st Century Road to Housing Act. This legislation, currently stalled in Congress, aims to prioritize homeownership for individuals over corporations. Trump highlighted the issue in a recent post on Truth Social, referencing the challenges faced by individuals like Houston resident Raysall Wiggins, who struggled to purchase a home due to competition from investors. The bill has faced opposition from builders and housing industry groups who argue that institutional investors contribute to housing inventory and that the proposed requirement for build-to-rent developers to sell homes within seven years could hinder market growth.